CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-08 | Hippel James Chief Financial Officer | Grant or award · Restricted Stock Units | +3,383 | 3,383 | ||
| 2018-08-08 | Hippel James Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +24,089 | 24,089 | ||
| 2018-08-08 | Hippel James Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +18,066 | 18,066 | ||
| 2018-08-07 | Kummeth Charles R. Chief Executive Officer | Option exercise | +13,816 | 90,288 | ||
| 2018-08-07 | Kummeth Charles R. Chief Executive Officer | Shares withheld for taxes | −6,301 | $180.14 | $1.1M | 83,987 |
| 2018-08-07 | Kummeth Charles R. Chief Executive Officer | Shares withheld for taxes | −1,752 | $180.14 | $316K | 82,235 |
| 2018-08-07 | Kummeth Charles R. Chief Executive Officer | Option exercise · Restricted Stock Units | −13,816 | 3,467 | ||
| 2018-08-07 | Kummeth Charles R. Chief Executive Officer | Returned to the company · Restricted Stock Units | −3,467 | 0 | ||
| 2018-08-07 | Kummeth Charles R. Chief Executive Officer | Returned to the company · Stock Options (Right to buy) | −23,929 | 95,346 | ||
| 2018-08-07 | Eansor Norman David SVP - Novus Biologicals | Option exercise | +1,199 | 3,465 | ||
| 2018-08-07 | Eansor Norman David SVP - Novus Biologicals | Shares withheld for taxes | −348 | $180.14 | $63K | 3,117 |
| 2018-08-07 | Eansor Norman David SVP - Novus Biologicals | Option exercise · Restricted Stock Units | −1,199 | 301 | ||
| 2018-08-07 | Eansor Norman David SVP - Novus Biologicals | Returned to the company · Restricted Stock Units | −301 | 0 | ||
| 2018-08-07 | Eansor Norman David SVP - Novus Biologicals | Returned to the company · Stock Options (Right to buy) | −1,881 | 7,494 | ||
| 2018-08-07 | Furlow Brenda S. SVP - General Counsel | Option exercise | +959 | 2,627 | ||
| 2018-08-07 | Furlow Brenda S. SVP - General Counsel | Shares withheld for taxes | −438 | $180.14 | $79K | 2,189 |
| 2018-08-07 | Furlow Brenda S. SVP - General Counsel | Option exercise · Restricted Stock Units | −959 | 241 | ||
| 2018-08-07 | Furlow Brenda S. SVP - General Counsel | Returned to the company · Restricted Stock Units | −241 | 0 | ||
| 2018-08-07 | Furlow Brenda S. SVP - General Counsel | Returned to the company · Stock Options (Right to buy) | −1,505 | 5,995 | ||
| 2018-08-07 | Hippel James Chief Financial Officer | Option exercise | +2,398 | 5,477 |
Page 55 of 64 · 1,274 trades